Interestingly, our results are similar to those reported for patients with drug-induced osteonecrosis, who show increased IL-6 levels in the local lesion and/or in the circulation (Bagan et al., 2014; Badros et al., 2021; Paschalidi et al., 2021). Here, IL6 is linked to osteonecrosis.